pentoxifylline also known oxpentifylline xanthine derivative used drug treat muscle pain people peripheral artery generic sold many brand names primary use medicine reduce pain cramping numbness weakness arms legs occurs due intermittent claudication form muscle pain resulting peripheral artery fda mhra tgalabelled however pentoxifylline also recommended offlabel use adjunct compression bandaging treatment chronic venous leg ulcers scottish intercollegiate guidelines network sign shown improve healing pentoxifylline tested use sarcoidosis patients alternative compliment prednisone steroids drug inhibit excess levels tnfa associated granuloma used treat immunologic reactions leprosy benefit alcoholic hepatitis shown studies demonstrating reduction risk hepatorenal syndromecitation needed vitro fertilization pentoxifylline used improve sperm quality safe oral drug treatment male infertility erectile interesting offlabel indication pentoxifylline supportive treatment distal diabetic neuropathy added example thioctic acid theoretically among things act prophylactically ulcerative changes lower limbs associated chronically decompensated diabetes patients measurable impairment arterial supply likely benefit adjunctive treatment administration higher doses pentoxifylline hospitalization complications distal diabetic neuropathy usually conditioned joint agreement neurologist physicians internal medicine diabetology angiology combination tocopherol pentoxifylline evaluated treatment medicationrelated osteonecrosis common side effects belching bloating stomach discomfort upset nausea vomiting indigestion dizziness flushing uncommon rare side effects include angina palpitations hypersensitivity itchiness rash hives bleeding hallucinations arrhythmias aseptic contraindications include intolerance pentoxifylline xanthine derivatives recent retinal cerebral haemorrhage risk factors like methylated xanthine derivatives pentoxifylline competitive nonselective phosphodiesterase raises intracellular camp activates pka inhibits synthesis reduces inflammation innate addition pentoxifylline improves red blood cell deformability known haemorrheologic effect reduces blood viscosity decreases potential platelet aggregation blood clot pentoxifylline also antagonist adenosine evidence pentoxifylline lower levels biomarkers nonalcoholic steatohepatitis evidence insufficient determine drug safe effective animal studies conducted exploring use pentoxifylline erectile hearing human studies conducted peyronies pentoxifylline combination tocopherol clodronate found heal refractory osteoradionecrosis prophylactic cochrane systematic review use pentoxifylline intermittent claudication following concluded quality included studies generally low large variability studies noted reported findings including duration trials doses pentoxifylline distances participants could walk start trials included studies report randomisation techniques treatment allocation concealed provide adequate information permit judgement selective reporting report blinding outcome assessors given factors role pentoxifylline intermittent claudication remains uncertain although medication generally well tolerated update httpsenwikipediaorgwikipentoxifylline